News

U.S. Pfizer Records 10 Percent Growth in Q2 Revenue
Pfizer, the U.S.-based pharmaceutical giant, revealed its second-quarter financial results on Tuesday, showcasing a robust 10 ...
Pfizer Q2 Earnings Review: Upside At Last As CEO Prepares For Trump Policy Battle
Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...
Pharmaceutical Technology on MSN18h
Pfizer shares rise 3% after upping profit forecast for 2025
"Pfizer shares rise 3% after upping profit forecast for 2025" was originally created and published by Pharmaceutical ...
Pfizer Q2 Results: Pharma major's sales jump to $14.65 billion; firm raises profit forecast for 2025 over cost cuts
Pharmaceutical major recorded a revenue jump to $14.65 billion, exceeding the market expectations. The company also raised ...
Pfizer stock pops as big pharma giant delivers post-COVID comeback
Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.
Buy Pfizer Stock At $24?
Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...
Pfizer: Earnings Meet Pressure (Rating Upgrade)
Pfizer's strong EPS surprise streak and positive earnings revisions are encouraging, but patent cliff risks remain a major ...
BioNTech's Q2 revenues double on higher COVID vaccine sales
German biotech firm BioNTech on Monday said that second-quarter revenues more than doubled to 261 million euros ($302 million ...